The invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNPs) and/or nucleoside hydrolases (NHs). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
本发明涉及一般式(I)的化合物,其为
嘌呤核苷酸磷酸酯酶(
PNP)和/或
核苷酸水解酶(NH)的
抑制剂。本发明还涉及这些化合物在治疗疾病和感染,包括癌症,细菌感染,原虫感染和T细胞介导的疾病中的使用,以及含有这些化合物的制药组合物。